11 completed, 1 terminated. 12 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 11, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Tapentadol: new trials by email Literature Review of Tapentadol trials Research Report on Tapentadol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opioid Induced Gait Variability Tapentadol 50 mg Oral Tablet, Tramadol Hydrochloride 100 mg Extended Release Oral Tablet, Placebo Oral Tablet - Opioid Induced Motor Disturbances | Phase 1 / Phase 2 | Completed | Frederiksberg University Hospital | 24 | 2015-05-19 | 2017-11-06 |
| A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain Tapentadol prolonged release, Morphine prolonged release - Pain | Phase 2 / Phase 3 | Completed | Grünenthal GmbH | 73 | 2015-04-29 | 2019-09-12 |
| Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old Tapentadol - Moderate to Severe Acute Postoperative Pain | Phase 2 | Terminated | Grünenthal GmbH | 40 | 2014-11-05 | 2018-01-29 |
| Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain Tapentadol - Postoperative Pain, Acute Pain | Phase 2 | Completed | Grünenthal GmbH | 86 | 2012-11-01 | 2019-11-04 |
| Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005 - Low Back Pain | Phase 2 | Completed | Tris Pharma, Inc. | 1089 | 2012-11-01 | 2021-07-15 |
| Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents Tapentadol (OS) Oral Solution - Pain, Postoperative, Postoperative Pain | Phase 2 | Completed | Janssen Research & Development, LLC | 45 | 2011-10-01 | 2014-07-14 |
| Intravenous Tapentadol in Post-Bunionectomy Pain Tapentadol, Matching Placebo - Bunion, Pain | Phase 2 | Completed | Grünenthal GmbH | 177 | 2011-09-01 | 2019-10-28 |
| A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia Tapentadol, Placebo - Pain, Diabetic Neuropathies | Phase 2 | Completed | Janssen Pharmaceutical K.K. | 91 | 2010-06-01 | 2014-01-13 |
| An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants Tapentadol Hydrochloride, Placebo - Pain, Low Back Pain | Phase 2 | Completed | Janssen Pharmaceutical K.K. | 91 | 2010-04-01 | 2013-05-14 |
| Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants Tapentadol PR - Pain, Cancer | Phase 2 | Completed | Janssen Pharmaceutical K.K. | 78 | 2008-11-01 | 2013-07-29 |
| A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery tapentadol HCl - Pain, Postoperative Pain | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 480 | 2005-01-01 | 2011-05-18 |
| Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis tapentadol HCl - Osteoarthitis, Chronic Pain | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 670 | 2004-07-01 | 2011-05-18 |
Pain (6) · Pain, Postoperative (5) · Acute Pain (3) · Chronic Pain (3) · Agnosia (2) · Low Back Pain (2) · Back Pain (1) · Bunion (1) · Diabetic Neuropathies (1) · Neoplasms (1) · Neuralgia (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1)
Grünenthal GmbH (4) · Janssen Pharmaceutical K.K. (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Frederiksberg University Hospital (1) · Janssen Research & Development, LLC (1) · Tris Pharma, Inc. (1)
United States (4) · Japan (3) · Spain (3) · United Kingdom (3) · Belgium (2) · Denmark (2) · France (2) · Germany (2) · Hungary (2) · Poland (2) · Austria (1) · Bulgaria (1) · Canada (1) · Chile (1) · Finland (1)
PMID 25985806, PMID 30649458, PMID 31213888
2014 (1)